Geron R&D Spending Growth & History (GERN)
Geron's r&d spending was $71.4M for fiscal 2025.
View full Geron company overviewGeron annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $71.4M | −$32.3M | −31.14% |
| 2024 | 2024-12-31 | $103.7M | −$21.3M | −17.04% |
| 2023 | 2023-12-31 | $125.0M | $29.5M | +30.91% |
| 2022 | 2022-12-31 | $95.5M | $9.8M | +11.42% |
| 2021 | 2021-12-31 | $85.7M | $34.2M | +66.50% |
| 2020 | 2020-12-31 | $51.5M | −$584,000 | −1.12% |
| 2019 | 2019-12-31 | $52.1M | $38.6M | +287.67% |
| 2018 | 2018-12-31 | $13.4M | $2.4M | +21.74% |
| 2017 | 2017-12-31 | $11.0M | −$7.0M | −38.87% |
| 2016 | 2016-12-31 | $18.0M | $216,000 | +1.21% |
| 2015 | 2015-12-31 | $17.8M | −$2.9M | −13.89% |
| 2014 | 2014-12-31 | $20.7M | −$2.4M | −10.57% |
| 2013 | 2013-12-31 | $23.2M | −$28.2M | −54.92% |
| 2012 | 2012-12-31 | $51.4M | −$17.9M | −25.89% |
| 2011 | 2011-12-31 | $69.3M | $7.6M | +12.37% |
| 2010 | 2010-12-31 | $61.7M | $4.1M | +7.06% |
| 2009 | 2009-12-31 | $57.6M | — | — |
Geron quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $22.0M | $294,000 | +1.35% |
| Q1 2026 | 2026-03-31 | $15.0M | −$122,000 | −0.81% |
| Q4 2025 | 2025-12-31 | $13.5M | −$9.9M | −42.18% |
| Q3 2025 | 2025-09-30 | $21.1M | $917,000 | +4.55% |
| Q2 2025 | 2025-06-30 | $21.7M | −$9.0M | −29.38% |
| Q1 2025 | 2025-03-31 | $15.1M | −$14.3M | −48.67% |
| Q4 2024 | 2024-12-31 | $23.4M | −$9.5M | −28.80% |
| Q3 2024 | 2024-09-30 | $20.2M | −$9.3M | −31.51% |
| Q2 2024 | 2024-06-30 | $30.8M | −$4.7M | −13.27% |
| Q1 2024 | 2024-03-31 | $29.4M | $2.2M | +7.91% |
| Q4 2023 | 2023-12-31 | $32.9M | $4.7M | +16.66% |
| Q3 2023 | 2023-09-30 | $29.4M | $4.8M | +19.60% |
| Q2 2023 | 2023-06-30 | $35.5M | $14.9M | +72.23% |
| Q1 2023 | 2023-03-31 | $27.2M | $5.1M | +23.17% |
| Q4 2022 | 2022-12-31 | $28.2M | $4.1M | +16.81% |
| Q3 2022 | 2022-09-30 | $24.6M | $6.1M | +32.80% |
| Q2 2022 | 2022-06-30 | $20.6M | −$1.3M | −6.07% |
| Q1 2022 | 2022-03-31 | $22.1M | $986,000 | +4.67% |
| Q4 2021 | 2021-12-31 | $24.1M | $7.9M | +48.82% |
| Q3 2021 | 2021-09-30 | $18.5M | $4.9M | +36.10% |
| Q2 2021 | 2021-06-30 | $21.9M | $11.1M | +102.28% |
| Q1 2021 | 2021-03-31 | $21.1M | $10.3M | +95.45% |
| Q4 2020 | 2020-12-31 | $16.2M | −$8.7M | −34.89% |
| Q3 2020 | 2020-09-30 | $13.6M | $2.5M | +22.54% |
| Q2 2020 | 2020-06-30 | $10.8M | $711,000 | +7.02% |
| Q1 2020 | 2020-03-31 | $10.8M | $4.9M | +82.90% |
| Q4 2019 | 2019-12-31 | $24.9M | $19.8M | +390.51% |
| Q3 2019 | 2019-09-30 | $11.1M | $8.4M | +310.38% |
| Q2 2019 | 2019-06-30 | $10.1M | $6.9M | +216.29% |
| Q1 2019 | 2019-03-31 | $5.9M | $3.5M | +142.05% |
| Q4 2018 | 2018-12-31 | $5.1M | $2.6M | +101.39% |
| Q3 2018 | 2018-09-30 | $2.7M | $70,000 | +2.65% |
| Q2 2018 | 2018-06-30 | $3.2M | $705,000 | +28.21% |
| Q1 2018 | 2018-03-31 | $2.4M | −$934,000 | −27.68% |
| Q4 2017 | 2017-12-31 | $2.5M | −$1.6M | −38.76% |
| Q3 2017 | 2017-09-30 | $2.6M | −$1.7M | −38.94% |
| Q2 2017 | 2017-06-30 | $2.5M | −$2.1M | −45.38% |
| Q1 2017 | 2017-03-31 | $3.4M | −$1.7M | −32.96% |
| Q4 2016 | 2016-12-31 | $4.1M | $138,000 | +3.47% |
| Q3 2016 | 2016-09-30 | $4.3M | $269,000 | +6.64% |
| Q2 2016 | 2016-06-30 | $4.6M | −$237,000 | −4.93% |
| Q1 2016 | 2016-03-31 | $5.0M | $46,000 | +0.92% |
| Q4 2015 | 2015-12-31 | $4.0M | −$369,000 | −8.48% |
| Q3 2015 | 2015-09-30 | $4.0M | −$1.9M | −32.43% |
| Q2 2015 | 2015-06-30 | $4.8M | −$339,000 | −6.58% |
| Q1 2015 | 2015-03-31 | $5.0M | −$224,000 | −4.30% |
| Q4 2014 | 2014-12-31 | $4.4M | −$660,000 | −13.17% |
| Q3 2014 | 2014-09-30 | $6.0M | $656,000 | +12.29% |
| Q2 2014 | 2014-06-30 | $5.2M | $344,000 | +7.16% |
| Q1 2014 | 2014-03-31 | $5.2M | −$2.8M | −34.85% |
| Q4 2013 | 2013-12-31 | $5.0M | −$6.8M | −57.53% |
| Q3 2013 | 2013-09-30 | $5.3M | −$6.3M | −54.31% |
| Q2 2013 | 2013-06-30 | $4.8M | −$8.0M | −62.38% |
| Q1 2013 | 2013-03-31 | $8.0M | −$7.1M | −47.05% |
| Q4 2012 | 2012-12-31 | $11.8M | −$7.9M | −40.02% |
| Q3 2012 | 2012-09-30 | $11.7M | −$4.7M | −28.52% |
| Q2 2012 | 2012-06-30 | $12.8M | −$3.8M | −22.77% |
| Q1 2012 | 2012-03-31 | $15.1M | −$1.6M | −9.84% |
| Q4 2011 | 2011-12-31 | $19.7M | — | — |
| Q3 2011 | 2011-09-30 | $16.3M | $2.6M | +19.06% |
| Q2 2011 | 2011-06-30 | $16.5M | $3.2M | +23.56% |
| Q1 2011 | 2011-03-31 | $16.8M | — | — |
| Q3 2010 | 2010-09-30 | $13.7M | — | — |
| Q2 2010 | 2010-06-30 | $13.4M | — | — |
Geron r&d spending trends
Over the last five fiscal years, Geron's r&d spending increased from $51.5M to $71.4M, a change of $19.9M. The latest reported quarter, Q2 2026, shows $22.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Geron source filings ↗